Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01630161 · ClinicalTrials.gov registry record · NA
Smoking Relapse-Prevention Intervention for Cancer Patients
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 441
- Enrollment target
NCT01630161: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01630161 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 441 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01630161, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 441 participants
- Enrollment target
Study Summary
The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.
Primary Outcome
Number of participants with smoking relapse at 6 months follow-up for each treatment arm.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Smoking Relapse Prevention for Cancer Patients (SRP-CaP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 441 participants |
| Start Date | 2012-01-04 |
| Est. Completion | 2020-11-18 |
| Phase | NA |
What the finished NCT01630161 record still lists
NCT01630161 is an interventional study that assigns participants to a tested intervention. The registered 441 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01630161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01630161 about?
NCT01630161 is a clinical study titled "Smoking Relapse-Prevention Intervention for Cancer Patients". The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.
What is the current status of trial NCT01630161?
This trial is currently completed. It is a NA study. The enrollment target is 441 participants. The study started on 2012-01-04. Estimated completion is 2020-11-18.
What interventions are being tested in trial NCT01630161?
The interventions under investigation include: Usual Care (BEHAVIORAL), Smoking Relapse Prevention for Cancer Patients (SRP-CaP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01630161?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01630161's enrollment target sits among peer trials
441 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02679144 · 441 participants · Phase 2
Neuroblastoma Maintenance Therapy Trial
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI